Results 101 to 110 of about 259,058 (180)

Maternal nutrition as a key determinant of placental and developing blood–brain barrier xenobiotic protective functions

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Suboptimal maternal nutrition alters placental and developing blood–brain barrier (BBB) protective function and is associated with increased fetal brain vulnerability. In the placenta, nutritional adversity may reduce the exchange surface area and promote meta‐inflammation, compromising barrier efficiency in a model‐ and context ...
Kristin L. Connor   +4 more
wiley   +1 more source

Investigating the Effect of Lapatinib on the Performance of Sonodynamic Therapy Against Prostate Cancer via Inhibition of the ABCG2 Efflux System

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 6, December 2026.
ABSTRACT Sonodynamic therapy (SDT) is an emerging site specific and minimally‐invasive modality for cancer treatment. Its efficacy heavily relies on the accumulation and retention of systemically‐administered sensitizing agents within tumor cells.
Yidong Wang   +2 more
wiley   +1 more source

Robot‐Assisted Radical Prostatectomy Using the Hugo RAS System: The First 15 Cases by a First‐Year Novice Surgeon Without Prior Console Experiences

open access: yesThe International Journal of Medical Robotics and Computer Assisted Surgery, Volume 22, Issue 6, December 2026.
ABSTRACT Background No study has specifically addressed the initial supervised experience of novice surgeons using the Hugo RAS system. Methods We retrospectively reviewed patients with prostate cancer receiving robot‐assisted radical prostatectomy (RARP).
Che‐Hsueh Yang   +7 more
wiley   +1 more source

Accessing and Navigating Gender‐Affirming Hormone Therapy and Perspectives on Inclusive Pharmacy Care Among Transgender and Gender Diverse People: A Qualitative Study

open access: yesHealth Expectations, Volume 29, Issue 6, December 2026.
ABSTRACT Introduction Transgender and gender diverse (TGD) people continue to experience inequities in access to gender‐affirming care, including stigmatisation, delayed treatment and non‐inclusive healthcare encounters. Community pharmacies may represent an accessible setting to support inclusive and affirming care; however, lived experiences of ...
Jessica McCann   +5 more
wiley   +1 more source

The Boron–Neuron Connection: The Potential of Boron‐Containing Molecules for Treating Incurable Amyotrophic Lateral Sclerosis

open access: yesChemMedChem, Volume 21, Issue 21, 12 November 2026.
Can a single element help address the multifactorial nature of ALS? Boron‐containing compounds combine responsiveness to reactive oxygen species (ROS), neuroprotective activity, and favorable pharmacological properties, offering a distinctive framework for disease modification in a complex disease like ALS.
Nitesh Sanghai   +5 more
wiley   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, Volume 20, Issue 11, Page 2896-2917, November 2026.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Castration‐resistant prostate cancer cells are addicted to the high activity of cyclin‐dependent kinase 2

open access: yesMolecular Oncology, Volume 20, Issue 11, Page 2699-2717, November 2026.
We show that emergence of castration‐resistant prostate (CRPC) is associated with significant upregulation of cyclins that positively regulate cyclin‐dependent kinase 2 (CDK2) and concomitant downregulation of CDK4 cyclins. This renders CRPC cells dependent on the high activity of CDK2, and CDK2 inhibitors synergistically sensitize CRPC cells to both ...
Joyeeta Chatterjee   +3 more
wiley   +1 more source

Androgen receptor signaling in prostate cancer: Genetic and molecular aspects

open access: yes, 2014
The prostate is an accessory sex gland of the male reproductive system, which produces alkaline prostatic fluid, capable of ensuring the spermatic viability to fertilize eggs within the female reproductive system.
Fioruci-Fontanelli, B. A. [UNESP]   +2 more
core  

EP300‐Mediated MTF1‐K218 Lactylation Buffers AR‐Driven Copper Overload to Suppress Cuproptosis in Castration‐Resistant Prostate Cancer

open access: yesAdvanced Science, Volume 13, Issue 61, 3 November 2026.
Androgen receptor (AR) drives copper accumulation in prostate cancer while inducing MTF1 to buffer copper toxicity. EP300‐mediated lactylation of MTF1 at K218 promotes its nuclear translocation and metallothionein expression, sequestering cytosolic copper and preventing mitochondrial cuproptosis.
Kai Li   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy